Key result
Review examines evolving commercial and prescription long-term rhythm monitoring technologies for post-ablation AF.
Why the study?
With the emergence of long-term, nonprescribed, wearable- and smartphone-based cardiac monitoring devices, practitioners face challenges interpreting these data for clinical decision-making regarding AF monitoring after catheter or surgical ablation.
This review explores the evolving landscape of long-term rhythm monitoring technologies, including wearables and smartphone-based devices, for patients following atrial fibrillation ablation.
May inform post-ablation AF monitoring choices; leaves open need for prospective validation of wearables.
In recent years, there has been an emergence of long-term cardiac monitoring devices, particularly as they relate to nonprescribed, user-initiated, wearable- and/or, smartphone-based devices. With these new available data, practitioners are challenged to interpret these data in the context of routine clinical decision-making. While there are many potential uses for long-term rhythm monitoring, in this review, we will focus on the evolving role of this technology in atrial fibrillation (AF) monitoring after catheter and/or surgical ablation. Here, we explore the landscape of prescription-based tools for long-term rhythm monitoring; investigate commercially available technologies that are accessible directly to patients, and look towards the future with investigative technologies that could have a growing role in this space.
No takes yet. Share an insight, caveat, or question.
Baman et al. (2022) conducted a review in Atrial fibrillation after catheter and/or surgical ablation. Long-term cardiac monitoring devices was evaluated. This review explores the evolving role of prescription-based and commercially available long-term rhythm monitoring technologies for atrial fibrillation after catheter or surgical ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: